(Q42602131)

English

Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials

scientific article published on November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 November 2017

0 references

Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

3 November 2017

ocular hypertension

1 reference

based on heuristic

inferred from title

open-angle glaucoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ni Li

1

1 reference

Europe PubMed Central

3 November 2017

Xiao-ming Chen

2

1 reference

Europe PubMed Central

3 November 2017

Yong Zhou

3

1 reference

Europe PubMed Central

3 November 2017

Mao-ling Wei

4

1 reference

Europe PubMed Central

3 November 2017

Xun Yao

5

1 reference

Europe PubMed Central

3 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2006

1 reference

Europe PubMed Central

3 November 2017

Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

3 November 2017

34

1 reference

Europe PubMed Central

3 November 2017

8

1 reference

Europe PubMed Central

3 November 2017

755-764

1 reference

Europe PubMed Central

3 November 2017

Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Therapeutic potential of prostaglandin analogues in glaucoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Primary drug treatment for glaucoma: beta-blockers versus other medications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Prostaglandin analog treatment of glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Estimating the long-term visual field consequences of average daily intraocular pressure and variance : a clinical trial comparing timolol, latanoprost and travoprost

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Human Ciliary Muscle Cell Responses to FP-Class Prostaglandin Analogs: Phosphoinositide Hydrolysis, Intracellular Ca2+ Mobilization and MAP Kinase Activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Mechanism and clinical significance of prostaglandin-induced iris pigmentation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Medical therapy cost considerations for glaucoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01237.X

21 January 2018

Identifiers

10.1111/J.1442-9071.2006.01237.X

1 reference

Europe PubMed Central

3 November 2017

1 reference

Europe PubMed Central

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42602131&oldid=1962565183"